Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Welland CAO Optimistic for 2026
Niagara Clinics Help Coughs, Colds
Clifton Hill Construction in January
Gas Prices to Hold Steady: Analyst
NRP Using Warrant in Niagara Falls Area
Part of Welland Canal Officially Named
Girl Assaulted in Break and Enter
Invest in Officer Well-Being: Former Chair